Seven years of qualification
Audited Supplier
In This Store
Yiling Pharma established an international pharmaceutical platform in Beijing and Shijiazhuang with annual capacity of 6.4 billion tablets (capsules). Facilities was designed by world-class design firm with the GMP standard of US FDA and EU, and have been certified by US FDA, MHRA, China NMPA, TGA, Health Canada and Medsafe for many times. Yiling Pharma is one of the few companies which both certified by USFDA and MHRA.
Main Business and Advantages
CMO service: from submission to commercial batch for API and FDF
CSO service: for China market including Rx and OTC
Product supply: own-label product (CN and US ANDA products) for worldwide
Regulatory support: for CMO worldwide and CSO for CN
Year of Establishment: 2014
Total Assets(USD):
Total Number of Staff: 500-1000
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: Strong CMO Capability Various Technology, Dosage Forms and Flexible Batch Size Multiple technology: granulation (wet, dry), pelleting tableting, contained processing Multiple dosage form: general and ER tablets/capsules, injection (vial, ampoule and lyophilized) Flexible batch size: linear scale-up capabilities from 1-1600kg Abundant CMO Experience 10+ Innovative drugs with different clients, and several have been launched 15+ Generic drugs wit different clients, and some varieties are pending approval 30+ Approved site transfer for partners in China, UK, Canada, New Zealand and other countries and commercial production is opening Excellent Project Operation Experienced staff for expeditious technology transfer Fully automated manufacturing Consummate record system is still in continuous refinement phase Excellent on-time delivery track record
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
